SynergyMed is a medical device company focused on the development of cancer tumor treatment products based on its innovative noninvasive ablation technology. The company is currently at the clinical stage. SynergyMed platform technology may be used as an alternative to surgery for the treatment of early stage breast, head & neck, skin, and lung cancers for humans and also for the veterinary market (cats, dogs and horses). The proven technology can locally ablate and destroy cancer tumors, precisely and effectively, without causing any damage to the surrounding healthy tissues. The company has an experienced team with backgrounds from leading corporate and academic institutions. SynergMed is currently seeking funding and strategic partnerships.